Evidence map›Paper›PMID 34260578›Full record

ArticleArchivos de cardiologia de Mexico2022

[Relación entre enfermedad cardiovascular y renal en una muestra de pacientes con diabetes del mundo real].

Emiliano Salmeri, Alicia Elbert, Augusto Lavalle-Cobo, Florencia Aranguren, Hugo Sanabria, Mariano Giorgi, Ezequiel Forte

Abstract readMulticenter Study
In one paragraph

Article in Archivos de cardiologia de Mexico, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emiliano SalmeriConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Alicia ElbertConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Augusto Lavalle-CoboConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Florencia ArangurenConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Hugo SanabriaConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Mariano GiorgiConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.
Ezequiel ForteConsejo de Cardiometabolismo de la Sociedad Argentina de Cardiología. Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Kidney disease is one of the microvascular complications of diabetes mellitus (DM) with little research and a strong association with cardiovascular disease (CVD). The objective of this study is to characterize the prevalence of kidney disease in a population of patients with type 2 diabetes who attend outpatient control by cardiology, to evaluate its degree of investigation and whether its presence impacts on the achievement of therapeutic goals and use of antidiabetics with cardiovascular and kidney protective effect. Methods: Cross-sectional, observational and multicenter study, carried out in 44 centers in Argentina between May and July 2019. Results: A population with 693 patients with DM was included. The prevalence of CVD was 47.5% (329 patients) and that of microvascular disease was 42.3%. Albuminuria was evaluated only in 46.2% of the patients and was significantly higher in the group with renal impairment (RI). The presence of CVD in patients with RI was greater than in those without RI (64.8% vs. 42.2%; p = 0.0001). The presence of albuminuria was associated with a higher prevalence of CVD. The achievement of therapeutic goals was scarce and no differences were evidenced based on the presence of RI, except for the LDL goal. Low prescription of antidiabetic drugs with proven cardiovascular and kidney benefit was observed. Conclusions: This study highlights the importance of the active search for kidney disease in patients with DM, exposing the low scope of therapeutic goals and the prescription of antidiabetic drugs with cardiovascular and kidney benefit.

Indexed as

Cardiovascular DiseasesDiabetes Mellitus, Type 2AlbuminuriaCross-Sectional StudiesHumansHypoglycemic AgentsRetrospective StudiesHypoglycemic AgentsAlbuminuriaCardiovascular diseaseCardiovascular riskDiabetes mellitusKidney diseaseReal world evidenceRenal impairment

Identifiers

PMID34260578
PMCPMC9005173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.